Zhejiang Benli Technology Co., Ltd. (hereinafter referred to as "the Company" or "Benli Technology") convened the 12th meeting of the 4th Board of Directors on March 31, 2026, and reviewed and approved the proposal on changes to part of the use of raised funds, adjustment of the total investment amount, and delay of some funded projects. The Company agreed to change part of the use of raised funds for the investment project "Technological Transformation of Acrylic Ester Products Based on CO Carbonylation Reaction and New Construction of 2,4-Dichloro-5-Fluorobenzoyl Chloride Project," adjusting the total investment from RMB 162.22 million to RMB 149.08 million. The Company also agreed to change part of the use of raised funds for the investment project "Expansion of 2,4-Dichloro-5-Fluorobenzoyl Chloride and New Construction of Norfloxacin and Uracil Project," adjusting the total investment from RMB 145.61 million to RMB 194.75 million. Additionally, the expected completion date for the "Research and Development Center Construction Project" is postponed from June 30, 2026, to June 30, 2027. This change in the use of part of the raised funds and adjustment of the total investment amount does not constitute a related party transaction or a major asset reorganization. The above matters still need to be submitted to the Company's first extraordinary general meeting of 2026 for deliberation. The Company will fulfill the relevant filing and approval procedures according to project supervision requirements after the shareholders' meeting approves the deliberation.
1. Basic Situation of Raised Funds
According to the approval from the China Securities Regulatory Commission on the registration of the initial public offering of Zhejiang Benli Technology Co., Ltd. (Zheng Jian Xu Ke [2021] No. 2601), the Company was authorized to publicly issue 17,680,000 shares of RMB ordinary shares (A shares), with a par value of RMB 1 per share and an issue price of RMB 42.50 per share, raising a total of RMB 751,400,000.00. After deducting the total issuance expenses of RMB 68,144,762.18 (excluding VAT), the actual net raised funds amounted to RMB 683,255,237.82. Lixin Accounting Firm (Special General Partnership) conducted an examination of the funds raised from the initial public offering on September 8, 2021, and issued the "Verification Report of Zhejiang Benli Technology Co., Ltd." (Xinhui Shi Bao Zi [2021] No. ZF10873).